Rising antibiotic costs as a potential driver of antimicrobial resistance in Nigeria

Antimicrobial Resistance (AMR) represents a critical global health challenge, undermining the efficacy of antibiotics and escalating the risks of severe infections. This perspective examines the sharp rise in antibiotic prices in Nigeria, highlighting a major barrier in the region’s healthcare system and its ongoing battle against AMR. We aim to investigate the key factors driving this increase: economic instability, heavy reliance on imported pharmaceuticals, and regulatory inefficiencies. These elements collectively restrict access to quality antibiotics, resulting in incomplete treatments and the proliferation of fake drugs. Our findings reveal a cyclical interaction where economic and regulatory challenges directly reduce the availability and quality of antibiotics, thereby diminishing treatment effectiveness and fostering the development of resistance. This aggravates the AMR crisis and underlines how systemic failures severely hinder healthcare delivery. The significant implications of these findings demand a comprehensive approach to mitigate this issue, including economic measures such as government subsidies, strengthened regulatory frameworks, enhanced public health education, and international cooperation. Ultimately, this commentary underlines the urgent need for coordinated efforts both domestically and globally to ensure effective antibiotic use and address the escalating threat of AMR. Implementing such an integrated strategy is vital not only to overcome the obstacles posed by high antibiotic costs but also to improve the overall effectiveness of the healthcare system in managing and preventing AMR.